Warning letters, 483s, Recalls, Import Alerts, Audit observations
Indian API manufacturer Jagsonpal Pharmaceuticals was issued a Warning Letter by the US FDA in
Indian API manufacturer Global Calcium Pvt Ltd was issued a Warning letter by USFDA in
FDA issued Warning letter to two Chinese API manufacturers following for cGMP violations including failing
The USFDA issued a warning letter in January 2025 to Sanofi’s API facility in Framingham,
FDA has published the Warning Letter issued to the Viatris Pithampur facility in December 2024. This Warning
New Delhi based Unexo Life Sciences has initiated a major recall of several medicated patch
Chinese OTC Manufacturer Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd was inspected by USFDA in March
Five different facilities of Eugia across India and US were inspected by USFDA between December
Following the USFDA 483 issued in April 2024 and the OAI classification in July 2024,
The USFDA issued a Warning Letter to the Chinese API manufacturer Chengdu KeCheng Fine Chemicals
